THE REFERENCES FROM THE BOOK "SURVIVAL 'TERMINAL' CANCER" BY BEN
WILLIAMS
Chapter 1 - Diagnosis: Glioblastoma multiforme "The
Terminator"
Chapter 2 - Searching for Treatment
Glioblastoma Newsletter, 24 Sept. 2002, Vol. 1, No. 5
Chapter 3 - Improving My Odds for Survival
Chapter 4 - Salvaging a Life
Chapter 5 - Toward a Rational Treatment Strategy
Chapter 6 - Shared Experiences
Glioblastoma Newsletter, 30 Oct. 2002, Vol.1, No.12
Chapter 7 - Conventions of
the Medical System and Their Ramifications
Chapter 8 -
Arbitrary Policies Exclude Promising Treatment
Chapter 9 -
Ethical Implications of the Clinical Trial System
Chapter 10 -
Phase-III Trials: Gold Standard or Fool's Gold?
Chapter 11 - Bastille Day
for Cancer Patient
Glioblastoma Newsletter, 2 Nov. 2002, Vol.1, No.13
Chapter 12 - Alternative
Medicine
Glioblastoma Newsletter, 3 Nov. 2002, Vol.1, No.14
Chapter 13 - The Value of
Supplements (I)
Glioblastoma Newsletter, 5 Nov. 2002, Vol.1, No.15
Chapter 13 - The Value of
Supplements (II)
Glioblastoma Newsletter, 6 Nov. 2002, Vol.1, No.16
The present issue completes the references of the
book.
The whole set of references is at the Section Overall Management of the website.
|
Chapter 14 - The
Cutting Edge of Cancer Treatment
|
| 1 |
Smith
TJ, Hillner BE, Desch CE
Efficacy and cost-effectiveness of cancer treatment:
rational allocation of resources based on decision analysis
J Natl Cancer Inst 1993
Sep 15;85(18):1460-74 (Review Article, Reference)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8360929&dopt=Abstract
|
| 2 |
HA
Fine, JS Loeffler, A Kyritsis, P Wen, PM Black, VA Levin, S Graham, WKA Yung
A phase II trial of the
anti-angiogenic agent,
thalidomide, in patients with recurrent high-grade gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1372 (Clinical Study)
Source:
http://www.asco.org/asco/publications/abstract_print_view/0,1144,_12-002324-00_29-00A-00_18-001997-00_19-0011797,00.html
|
| 3 |
Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in
Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract
No.
551 (Clinical Study)
Source:
http://www.asco.org/asco/publications/abstract_print_view/0,1144,_12-002324-00_29-00A-00_18-001999-00_19-0014804,00.html
|
| 4 |
N.A.
|
| 5 |
Boehm
T, Folkman J, Browder T, O'Reilly MS
Antiangiogenic
therapy of experimental cancer does not induce acquired drug resistance
Nature 1997 Nov 27;390(6658):404-7 (Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9389480&dopt=Abstract
|
| 6 |
Yokoyama
Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S
Synergy
between angiostatin and endostatin: inhibition of ovarian cancer growth
Cancer Res 2000 Apr 15;60(8):2190-6 (Animal Study, Abstract
| Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10786683&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://cancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=10786683
|
| 7 |
Gagliardi AR, Hennig B, Collins DC
Antiestrogens inhibit endothelial cell growth
stimulated by angiogenic growth factors
Anticancer Res 1996 May-Jun;16(3A):1101-6 (Cell Culture Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8702220&dopt=Abstract
|
| 8 |
Cai
J, Jiang WG, Mansel RE
Inhibition
of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid
Prostaglandins
Leukot Essent Fatty Acids 1999 Jan;60(1):21-9
(Cell Culture Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10319914&dopt=Abstract
|
| 9 |
Zhou
JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK
Soybean
phytochemicals inhibit the growth of transplantable human prostate carcinoma and
tumor angiogenesis in mice
J Nutr 1999
Sep;129(9):1628-35 (Animal Study, Abstract)
Source: http://www.nutrition.org/cgi/content/abstract/129/9/1628
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?http://nutrition.org/cgi/pmidlookup?view=full&pmid=10460196
|
| 10 |
Yihai
Cao and Renhai Cao
Angiogenesis inhibited by drinking tea
Nature 1999 Apr 1;398(6726):381 (Letter, Reference
| Full Text)
Source | Full Text:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10201368&dopt=Abstract
|
| 11 |
Arbiser
JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR
Curcumin is an
in vivo inhibitor of angiogenesis
Mol
Med 1998 Jun;4(6):376-83 (Cell
Culture Study | Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10780880&dopt=Abstract
|
| 12 |
Majewski
S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S
Vitamin D3 is a potent inhibitor of tumor
cell-induced angiogenesis
J Investig
Dermatol Symp Proc 1996 Apr;1(1):97-101 (Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9627702&dopt=Abstract
|
| 13 |
Jiang
C, Agarwal R, Lu J
Anti-angiogenic
potential of a cancer chemopreventive flavonoid antioxidant, silymarin:
inhibition of key attributes of vascular endothelial cells and angiogenic
cytokine secretion by cancer epithelial cells
Biochem Biophys Res Commun 2000 Sep 16;276(1):371-8
(Cell Culture Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11006131&dopt=Abstract
|
| 14 |
Verheul
HM, Panigrahy D, Yuan J, D'Amato RJ
Combination
oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth
in rabbits
Br J
Cancer 1999 Jan;79(1):114-8 (Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10408702&dopt=Abstract
|
| 15 |
Gorski
DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP,
Soff GA, Kufe DW, Weichselbaum RR
Potentiation of the antitumor effect of ionizing
radiation by brief concomitant exposures to angiostatin
Cancer Res 1998 Dec 15;58(24):5686-9 (Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9865723&dopt=Abstract
|
| 16 |
Li D, Williams JI, Pietras RJ
Squalamine
and cisplatin block angiogenesis and growth of human ovarian cancer cells with
or without HER-2 gene overexpression
Oncogene 2002 Apr 25;21(18):2805-14
(Cell Culture Study | Animal Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11973639&dopt=Abstract
|
| 17 |
N.A.
|
| 18 |
N.A.
|
| 19 |
Snelling
L, Miyamoto CT, Bender H, Brady LW, Steplewski Z, Class R, Emrich J, Rackover MA
Epidermal
growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in
the adjuvant treatment of high-grade astrocytomas
Hybridoma
1995 Apr;14(2):111-4 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7590764&dopt=Abstract
|
| 20 |
N.A.
|
| 21 |
N.A.
|
| 22 |
N.A.
|
| 23 |
Pietro Riva, Giancarlo Franceschi, Massimo Frattarelli, Nada Riva,
Graziano Guiducci, Anna Maria Cremonini, Graziano Giuliani, Michela Casi,
Rossella Gentile, Annti A. Jekunen, Kalevi J. A. Kairemo
131I
Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade
Malignant Glioma: Phase I and II Study
Acta Oncologica, Volume 38, Number 3/May 18, 1999, 351 - 359
(Clinical Study,
Abstract)
Source: http://taylorandfrancis.metapress.com/link.asp?id=gj5t0rv3ucvmwyw1
|
| 24 |
N.A.
|
| 25 |
Baselga
J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT,
Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L
Phase II study
of weekly intravenous trastuzumab (Herceptin) in patients with
HER2/neu-overexpressing metastatic breast cancer
Semin
Oncol 1999 Aug;26(4 Suppl 12):78-83
(Clinical Study,
Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10482197&dopt=Abstract
|
| 26 |
Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM,
Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, Slamon DJ
Phase II study of receptor-enhanced chemosensitivity
using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin
in patients with HER2/neu-overexpressing metastatic breast cancer refractory to
chemotherapy treatment
J Clin Oncol 1998 Aug;16(8):2659-71
(Clinical Study,
Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9704716&dopt=Abstract
|
| 27 |
Grillo-Lopez AJ, White CA, Varns C, Shen D, Wei A, McClure A,
Dallaire BK
Overview
of the clinical development of rituximab: first monoclonal antibody approved for
the treatment of lymphoma
Semin
Oncol 1999 Oct;26(5 Suppl 14):66-73
(Clinical Study,
Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10561020&dopt=Abstract
|
| 28 |
Klatzmann D, Valery CA, Bensimon G, Marro B, Boyer O, Mokhtari K,
Diquet B, Salzmann JL, Philippon J
A
phase I/II study of herpes simplex virus type 1 thymidine kinase
"suicide" gene therapy for recurrent glioblastoma. Study Group on Gene
Therapy for Glioblastoma
Hum
Gene Ther 1998 Nov 20;9(17):2595-604 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9853526&dopt=Abstract
|
| 29 |
Im SA, Gomez-Manzano C, Fueyo J, Liu TJ, Ke LD, Kim JS, Lee HY,
Steck PA, Kyritsis AP, Yung WK
Antiangiogenesis treatment for
gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo
Cancer
Res 1999 Feb 15;59(4):895-900 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10029081&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://cancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=10029081
|
| 30 |
Hayes
RL, Koslow M, Hiesiger EM, Hymes KB, Hochster HS, Moore EJ, Pierz DM, Chen
DK, Budzilovich GN, Ransohoff J
Improved long
term survival after intracavitary interleukin-2 and lymphokine-activated killer
cells for adults with recurrent malignant glioma
Cancer
1995 Sep 1;76(5):840-52 (Clinical Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8625188&dopt=Abstract
|
| 31 |
Plautz
GE, Barnett GH, Miller DW, Cohen BH, Prayson RA, Krauss JC, Luciano M,
Kangisser DB, Shu S
Systemic
T cell adoptive immunotherapy of malignant gliomas
J
Neurosurg 1998 Jul;89(1):42-51 (Clinical
Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9647171&dopt=Abstract
|
| 32 |
Liau
LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP,
Bronstein JM
Treatment
of intracranial gliomas with bone marrow-derived dendritic cells pulsed with
tumor antigens
J
Neurosurg 1999 Jun;90(6):1115-24
(Animal
Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10350260&dopt=Abstract
|
|
Volume 1, Number 17 - 7 November 2002